Mar 11, 2025, 17:08 by Sarah Shelson

Mar 5, 2025, 16:54 by Sarah Shelson

Mar 3, 2025, 12:11 by Emily Brunner, MD, DFASAM, Chwen-Yuen A. Chen, MD, FACP, FASAM, Chinyere Ogbonna, MD, MPH, Tricia Wright, MD, MS, FACOG, DFASAM

This guideline was developed to help clinicians determine when the risks of continued BZD prescribing outweigh the benefits for a given patient and how to safely taper the medication when indicated. Existing guidelines generally recommend limiting duration of BZD use to 2-4 weeks (except for limited conditions such as severe treatment-resistant generalized anxiety disorder, complex seizure disorders, spasticity, and sleep disorders involving abnormal movements). However, long-term BZD prescribing remains prevalent.

Feb 27, 2025, 18:41 by Sarah Shelson

Feb 26, 2025, 17:22 by Sarah Shelson

Feb 26, 2025, 09:59 by ASAM Weekly Editors

Guest Editorial: New Clinical Practice Guideline - Benzodiazepine Tapering

Feb 19, 2025, 10:38 by ASAM Weekly Editors

Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality

Feb 18, 2025, 14:22 by Sarah Shelson

Feb 12, 2025, 15:37 by ASAM Weekly Editors

Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders

Feb 10, 2025, 16:59 by Sarah Shelson

Feb 10, 2025, 09:51 by ASAM Weekly Editors

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl

Feb 7, 2025, 16:06 by Kelly Corredor

Feb 3, 2025, 16:30 by Sarah Shelson

Jan 31, 2025, 14:06 by Sarah Shelson

Jan 30, 2025, 00:00 by Sarah Shelson

Jan 29, 2025, 15:10 by Sarah Shelson

Jan 29, 2025, 11:18 by ASAM Weekly Editors

Beyond Buprenorphine in the ED: Leveraging Lessons From 10 Years of Implementation

Jan 27, 2025, 10:29 by Sarah Shelson

Jan 27, 2025, 05:00 by Kenneth Minkoff, MD

The opioid toxicity crisis remains an urgent public health priority across the US and Canada. Since the seminal randomized controlled trial published in 2015 found that buprenorphine initiation in the emergency department (ED) was superior compared with referral to treatment alone, buprenorphine initiation in the ED has been hailed as an important mechanism for addressing the overdose crisis.

Jan 27, 2025, 00:00 by Sarah Shelson